← TrialMatch
HomeTrials

The Effect of PAP on ISSHL Comorbided With OSA

This clinical randomized controlled study is to explore the effect of positive airway pressure(PAP) on patients in Beijing Tsinghua Changgung Hospital diagnosed with both idiopathic sudden sensorineural hearing loss comorbided(ISSHL) and obstructive sleep apnea(OSA) between Dec. 2019 to Dec. 2029.

Condition(s)Sudden Hearing Loss, Obstructive Sleep Apnea
StatusRecruiting
PhasePhase 4
Study typeInterventional
SummaryThis clinical randomized controlled study is to explore the effect of positive airway pressure(PAP) on patients in Beijing Tsinghua Changgung Hospital diagnosed with both idiopathic sudden sensorineural hearing loss comorbided(ISSHL) and obstructive sleep apnea(OSA) between Dec. 2019 to Dec. 2029.
Who can participateInclusion Criteria: 1. aged \>= 18 and \<= 70, 2. diagnosed with OSA by full-night in-lab or home-stay PSG according to AASM 2012 criteria, and AHI \> 15/h, 3. diagnosed with ISSHL by AAO-HNS 2019 criteria, 4. ISSHL onset within 1 week. Exclusion Criteria: 1. sudden hearing loss with certain causes, 2. with severe comorbid diseases, 3. pregnant or breast-feeding women, 4. AHI \<= 15/h, 5. hearing threshold recovered \> 50% when included, 6. previously regularly treated with PAP.
Ages18 Years to 70 Years
SexAll
Lead sponsorBeijing Tsinghua Chang Gung Hospital
LocationsBeijing, Beijing Municipality, China
Start date2019-11-01
NCT IDNCT04192656
Official listinghttps://clinicaltrials.gov/study/NCT04192656

🔍 Search all trials →